DVA vs REX · P/E 14, rev $12.82B vs P/E 15, rev $642.5M
DaVita HealthCare Partners Inc (DVA) versus REX American Resources Corporation (REX) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
REX American Resources Corporation (REX) is a chemicals company listed on NYSE.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported REX revenue for 2025-01-31 was $642.5M. Net income was $71.5M. Revenue was down 22.9% from 2024-01-31 to 2025-01-31. REX currently screens at market cap $1.43B and trailing P/E 15.5.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. REX currently screens at market cap $1.43B and trailing P/E 15.5.
Not investment advice. Open the DVA and REX stock pages for the full models.
Not investment advice.